The Cancer Drugs Fund has led to a ‘devastating divide' in access to treatment between England and other home nations, according to a cancer charity.
Equal funding could be achieved across the nation at an extra cost of £1 per person per year for residents of Wales and England who are not able to access the fund, the Rarer Cancers Foundation (RCF) added. It found that people in Wales were five times less likely to get access to a newer cancer drug on the NHS than those in England, while those in Scotland were three times less likely. If funding and access levels were the same nationwide, it would benefit 159 more patients a year in Wales and 248 in Scotland. The charity's Nation Divided? report took aim at both the Scottish and ...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes